[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.94.5. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 796
Citations 0
Letters
November 21, 2012

Cardiovascular Disease Risk Prediction Factors

Author Affiliations
 

Letters Section Editor: Jody W. Zylke, MD, Senior Editor.

Author Affiliations: Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Montreal, Quebec, Canada (Dr Sniderman; allansniderman@hotmail.com); and Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina (Dr Furberg).

JAMA. 2012;308(19):1969. doi:10.1001/jama.2012.14049

To the Editor: The Emerging Risk Factors Collaboration1 (ERFC) reported on the addition of lipid-related markers to total cholesterol and high-density lipoprotein cholesterol (HDL-C) in the prediction of cardiovascular disease. We attempted to replicate the findings of eTable 1, which summarized the 26 studies that compared apolipoprotein B with the cholesterol markers.

First Page Preview View Large
First page PDF preview
First page PDF preview
×